DERMATOMYOSITIS

Clinical trials for DERMATOMYOSITIS explained in plain language.

Never miss a new study

Get alerted when new DERMATOMYOSITIS trials appear

Sign up with your email to follow new studies for DERMATOMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 17 Not yet recruiting 1 Not yet finished but already full! 7 Completed 7 Terminated 1

Experimental drug targets deadly lung complication in rare autoimmune disease

Disease control Not yet recruiting

This early study tests whether emapalumab, a drug used for a severe immune overreaction, can help people with a rare, rapidly worsening lung disease linked to anti-MDA5 antibodies. The trial will enroll 5 adults whose lung function is declining despite standard care. The main goa…

Matched conditions: DERMATOMYOSITIS

Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control

Last updated May 05, 2026 11:54 UTC

DERMATOMYOSITIS

Get alerted when new DERMATOMYOSITIS trials appear

Experimental drug targets deadly lung complication in rare autoimmune disease